Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Sonnet Biotherapeutics Holdings Inc (SONN)

2.42   -0.19 (-7.28%) 02-25 12:22
Open: 2.64 Pre. Close: 2.61
High: 2.68 Low: 2.41
Volume: 1,916,617 Market Cap: 42M
Sonnet Biotherapeutics Holdings Inc, formerly Chanticleer Holdings, Inc., an oncology-focused biotechnology company. The Company is developing targeted biologic drugs with enhanced single or bispecific mechanisms.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.664 - 2.679 2.679 - 2.692
Low: 2.511 - 2.53 2.53 - 2.548
Close: 2.582 - 2.61 2.61 - 2.636

Technical analysis

as of: 2021-02-25 11:51:08 AM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.54     One year: 3.99
Support: Support1: 2.40    Support2: 2.00
Resistance: Resistance1: 3.03    Resistance2: 3.42
Pivot: 2.93
Moving Average: MA(5): 2.67     MA(20): 2.88
MA(100): 2.63     MA(250): 4.20
MACD: MACD(12,26): -0.01     Signal(9): 0.07
Stochastic oscillator: %K(14,3): 14.38     %D(3): 20.89
RSI: RSI(14): 36.12
52-week: High: 54.60  Low: 2.20  Change(%): -75.8
Average Vol(K): 3-Month: 111269  10-Days: 143726

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
SONN has closed below the lower band by 2.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 76.9% wider than normal. The large width of the bands suggest high volatility as compared to SONN's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Thu, 18 Feb 2021
Where Will Chanticleer Holdings Common Stock (SONN) Stock Go Next After It Is Down 5.88% in a Week? - InvestorsObserver

Tue, 16 Feb 2021
Sonnet BioTherapeutics Provides Fiscal Year 2021 First Quarter Business and Earnings Update - BioSpace

Wed, 03 Feb 2021
How Will the Market React to Chanticleer Holdings Common Stock (SONN) Stock Getting a Bullish Rating - InvestorsObserver

Mon, 01 Feb 2021
Sonnet BioTherapeutics Completes Successful Repeat Dose Study of SON-1010 in Non-Human Primates - StreetInsider.com

Mon, 25 Jan 2021
Sonnet BioTherapeutics Announces the Successful Completion of a Non-human Primate Toxicology Study of SON-080 - Yahoo Finance

Thu, 17 Dec 2020
Sonnet BioTherapeutics Provides Fiscal Year 2020 Business and Earnings Update - Yahoo Finance

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 17
Shares Float (M) 15
% Held by Insiders 4.02
% Held by Institutions 2.62
Shares Short (K) 886
Shares Short P. Month (K) 960

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm) -270.9
Return on Equity (ttm) -27822.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.013
Qtrly Earnings Growth
Operating Cash Flow (M) -16
Levered Free Cash Flow (M) -9

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -2.70

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.